Case Problems in Finance / by Butters, J. Keith, editor 182331

Finance / by Harvey, D. A., author 286339, McLaney, Eddie J., author 286642

Electrical Distribution in Buildings / by Poole, C. Dennis, author 222452

An Introduction to Equations of State : Theory and Applications / by Eliezer, Shalom, editor 223451

BASIC Molecular Spectroscopy / by Gorry, P. A., author 223459

Perspectives in Fluid Mechanics / by Coles, Donald, editor 226175

Kamus simpulan bahasa / by Abdullah Hussain, 1920-2015

Breakthrough business negotiation : a toolbox for managers / by Watkins, Michael D., 1956-, 422691

CCDI architecture : design for China's future by China Construction Design International 9464

Hantu punya bos / by Dekna Lee 548711

Awek abang poyo / by 497360 Ummu Wafa

Hydraulics - Troubleshooting : CD-ROM Version 2.0

E-reader : BOOX Tab Mini C / by Onyx International Inc.

Essays in Malaysian law / by 188974 Hickling, R. H.

Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2 by Gu, Yue, Shunmuganathan, Bhuvaneshwari, Qian, Xinlei, Gupta, Rashi, Tan, Rebecca S. W., Kozma, Mary, Purushotorman, Kiren, Murali, Tanusya M., Tan, Nikki Y. J., Preiser, Peter Rainer, Lescar, Julien, Nasir, Haziq, Somani, Jyoti, Tambyah, Paul A., Smith, Kenneth G. C., Renia, Laurent, Ng, Lisa F. P., Lye, David C., Young, Barnaby E., MacAry, Paul A.

“…We also present an accurate quantitation of serological responses for SARS-CoV-2 that exploits a unique set of in-house, recombinant human monoclonal antibodies targeting the viral Spike and nucleocapsid proteins and demonstrate a reduction in neutralizing antibody titres across all groups 6 months post-vaccination. …”
Get full text

Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South A... by Costa Clemens, SA, Jepson, B, Bhorat, QE, Ahmad, A, Akhund, T, Aley, PK, Bansal, H, Bibi, S, Kelly, EJ, Khan, M, Lambe, T, Lombaard, JJ, Matthews, S, Pipolo Milan, E, Olsson, U, Ramasamy, MN, Moura de Oliveira Paiva, MS, Seegobin, S, Shoemaker, K, Szylak, A, Villafana, T, Pollard, AJ, Green, JA

“…<p><b>Background</b></p> AZD2816 is a variant-adapted COVID-19 vaccine that expresses the full-length SARS-CoV-2 beta variant spike protein but is otherwise similar to AZD1222 (ChAdOx1 nCoV-19). …”

Engineering Aspects of Thermonuclear Fusion Reactors / by Casini, G., editor 219030

The Future Propulsion Systems for the Maritime Transportation Sector / by Mohamad Afifi Abdul Mukti, author 173811, Akm Moazzem Hussain, author 220343

Wordstar in Action : Practical Examples for Instant Use / by McMullan, Randall, author 223050

Financial Accounting / by Fess, Philip E., author 270124, Warren, Carl S., author 270114